T. Fotsis et al., GENISTEIN, A DIETARY INGESTED ISOFLAVONOID, INHIBITS CELL-PROLIFERATION AND IN-VITRO ANGIOGENESIS, The Journal of nutrition, 125(3), 1995, pp. 790-797
Consumption of a plant-based diet can prevent the development and prog
ression of chronic diseases that are associated with extensive neovasc
ularization. To determine whether prevention might be associated with
dietary derived angiogenesis inhibitors, we have fractionated urine of
healthy human subjects consuming a plant-based diet and examined the
fractions for their abilities to inhibit the proliferation of vascular
endothelial cells. One of the most potent fractions contained several
isoflavonoids, which we identified by gas chromatography-mass spectro
metry and subsequently synthesized. Of all synthetic compounds, the is
oflavonoid genistein was the most potent and inhibited endothelial cel
l proliferation and in vitro angiogenesis at half maximal concentratio
ns of 5 and 150 mu mol/L, respectively. Moreover, genistein inhibited
the proliferation of various tumor cells. Genistein excretion in urine
of subjects consuming a plant-based diet is in the micromolar range,
which is 30-fold higher than that of subjects consuming a traditional
Western diet. The high concentrations of genistein in urine of vegetar
ians and our present results suggest that genistein may contribute to
the preventive effect of plant-based diet on chronic diseases, includi
ng solid tumors, by inhibiting neovascularization and tumor cell proli
feration. Thus genistein may have important applications in the treatm
ent of solid tumors and angiogenic diseases.